Osteoclast cytomorphometry demonstrates an abnormal population in B cell malignancies but not in multiple myeloma.
Increased bone resorption in the vicinity of myeloma cells is mediated by local stimulating factors. Other malignancies of the B cell lineage are also able to produce resorbing factors responsible for increased bone resorption. We have studied three groups of subjects: 10 patients with overt multiple myeloma, 10 patients with a B cell malignancy, and 10 healthy human subjects as controls. Patients were studied at the time of diagnosis and had a transiliac bone biopsy. Osteoclasts were evident on histological sections by their acid phosphatase activity. A software was developed on an automatic image analyzer (Leitz TAS+) for measuring the maximal Feret's diameter (Oc.Le) of each osteoclast (corresponding to the osteoclast length). The histogram of Oc.Le frequency distribution was supplied in each group. In myeloma patients, the Oc.Le frequency distribution was similar to that in normal subjects and showed the histogram to be asymetric with a positive skew (maximum peak at 20-25 microns). With a graphical analysis, this distribution was shown to follow a lognormal distribution corresponding to a homogeneous osteoclast population. In other B cell malignancies, Oc.Le displayed a bimodal distribution with a peak at 20-25 microns and a lower peak at 10-15 microns. The graphical analysis showed that small (mononucleated?) osteoclasts are present in B cell malignancies with normal osteoclasts. This might reflect the secretion of different soluble factors by malignant cells of the B lymphocyte lineage.
Chappard
D
D
LBTO--Laboratoire de Biologie du Tissu Osseux, Faculté de Médecine, Saint Etienne, France.
Rossi
J F
JF
Bataille
R
R
Alexandre
C
C
D000135:Acid Phosphatase / Q000378:metabolism; D001402:B-Lymphocytes / Q000201:enzymology / Q000473:pathology*; D001706:Biopsy; D001859:Bone Neoplasms / Q000201:enzymology / Q000473:pathology*; D001842:Bone and Bones / Q000201:enzymology / Q000473:pathology; D006801:Humans; D009101:Multiple Myeloma / Q000201:enzymology / Q000473:pathology*; D010010:Osteoclasts / Q000201:enzymology / Q000473:pathology*; D012984:Software; D013194:Staining and Labeling / Q000379:methods
D000135:Acid Phosphatase